Published in Phys Med Biol on June 01, 1998
In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol (1985) 2.46
In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects. Br J Ind Med (1988) 2.43
Partition of circulating lead between serum and red cells is different for internal and external sources of lead. Am J Ind Med (1996) 2.38
Unexpected mobilisation of lead during cisplatin chemotherapy. Lancet (1986) 1.95
Cadmium fume inhalation and emphysema. Lancet (1988) 1.84
In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine. Environ Res (1981) 1.81
In vivo X-ray fluorescence of lead in bone: review and current issues. Environ Health Perspect (1994) 1.74
In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health (1993) 1.47
In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites. Phys Med Biol (1989) 1.46
In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure. Br J Ind Med (1992) 1.37
Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res (1998) 1.35
Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements. Phys Med Biol (1986) 1.35
In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies. Environ Res (1992) 1.30
The reproducibility of 109Cd-based X-ray fluorescence measurements of bone lead. Environ Health Perspect (1994) 1.27
An improved instrument for the in vivo detection of lead in bone. Br J Ind Med (1993) 1.19
Accumulated body burden and endogenous release of lead in employees of a lead smelter. Environ Health Perspect (1997) 1.15
Effects of methandienone on the performance and body composition of men undergoing athletic training. Clin Sci (Lond) (1981) 1.14
Relationship between bone lead and other indices of lead exposure in smelter workers. Toxicol Lett (1995) 1.11
Kidney effects in long term exposed lead smelter workers. Br J Ind Med (1992) 1.11
Repeated measurements of tibia lead concentrations by in vivo x ray fluorescence in occupational exposure. Br J Ind Med (1992) 1.07
Further experience with bone lead content measurements in residents of southern Ontario. Appl Radiat Isot (1997) 1.07
Critical concentration of cadmium in renal cortex and urine. Lancet (1979) 1.07
Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med (1998) 1.06
Techniques of in vivo neutron activation analysis. Phys Med Biol (1984) 1.02
In vivo measurements of lead in bone using a 109Cd 'spot' source. Basic Life Sci (1993) 1.02
Ultrasound measurements of overlying soft tissue thickness at four skeletal sites suitable for in vivo x-ray fluorescence. Med Phys (2002) 0.98
Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect (1995) 0.98
In vivo elemental analysis in occupational medicine. Scand J Work Environ Health (1986) 0.97
Renal dysfunction in cadmium smelters: relation to in-vivo liver and kidney cadmium concentrations. Lancet (1983) 0.97
An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis. Magn Reson Imaging (2003) 0.95
In vivo X-ray fluorescence of lead in bone. Environ Res (1992) 0.94
In vivo measurements of bone lead content in residents of southern Ontario. Appl Radiat Isot (1994) 0.94
109Cd K x ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood. Occup Environ Med (2000) 0.94
Chelated lead and bone lead. Scand J Work Environ Health (1992) 0.93
Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers. Br J Ind Med (1988) 0.92
Factors affecting in vivo measurement precision and accuracy of 109Cd K x-ray fluorescence measurements. Phys Med Biol (1999) 0.88
An agreed statement on calculating lead concentration and uncertainty in XRF in vivo bone lead analysis. Appl Radiat Isot (2003) 0.87
Calculation of radiation doses for nonuniformity distributed beta and gamma radionuclides in soft tissue. Med Phys (1985) 0.87
Measurement of cadmium in liver and kidney using in vivo techniques. Ann Occup Hyg (1982) 0.86
Longitudinal studies of exposure to cadmium. Br J Ind Med (1992) 0.86
An improved in vivo neutron activation system for measuring kidney cadmium. Phys Med Biol (1990) 0.84
Modelling DNA damage induced by different energy photons and tritium beta-particles. Int J Radiat Biol (1998) 0.84
Measurement of whole-body nitrogen by neutron-activation analysis. Lancet (1973) 0.83
Hydration status assessed by multi-frequency bioimpedance analysis. Appl Radiat Isot (1998) 0.83
Effect of occupational lead exposure on serum 1,25-dihydroxyvitamin D levels. Hum Exp Toxicol (1990) 0.82
The feasibility of measuring bone uranium concentrations in vivo using source excited K x-ray fluorescence. Phys Med Biol (1997) 0.82
Lead concentrations in tibial and calcaneal bone in relation to the history of occupational lead exposure. Scand J Work Environ Health (1998) 0.81
In vivo study of an x-ray fluorescence system to detect bone strontium non-invasively. Phys Med Biol (2007) 0.81
Longitudinal changes in bone lead concentration: implications for modelling of human bone lead metabolism. J Environ Monit (2001) 0.80
The O'Flaherty model of lead kinetics: an evaluation using data from a lead smelter population. Toxicol Appl Pharmacol (1999) 0.80
Is there any association between the presence of bone disease and cumulative exposure to lead? Calcif Tissue Int (1998) 0.80
Quantification of bone strontium levels in humans by in vivo x-ray fluorescence. Med Phys (2004) 0.80
In vivo X-ray fluorescence (XRF) measurement of uranium in bone. Appl Radiat Isot (1998) 0.79
An enhanced sensitivity K-shell x-ray fluorescence technique for tibial lead determination. Phys Med Biol (1993) 0.79
Calculation of radiation-induced DNA damage from photons and tritium beta-particles. Part II: Tritium RBE and damage complexity. Radiat Environ Biophys (2001) 0.79
Improving the in vivo X-ray fluorescence (XRF) measurement of renal mercury. Appl Radiat Isot (2000) 0.79
In vivo measurement of bone aluminum in population living in southern Ontario, Canada. Med Phys (2008) 0.78
Opportunities to improve the in vivo measurement of manganese in human hands. Phys Med Biol (2008) 0.78
Monte Carlo modelling of in vivo x-ray fluorescence of lead in the kidney. Phys Med Biol (1991) 0.78
Effect of tissue inhomogeneity on dose distribution of point sources of low-energy electrons. Med Phys (1990) 0.78
An upgraded 109Cd K X-ray fluorescence bone Pb measurement. Basic Life Sci (1993) 0.78
Noninvasive measurement of aluminium in human bone: preliminary human study and improved system performance. J Inorg Biochem (2009) 0.78
Design studies related to an in vivo neutron activation analysis facility for measuring total body nitrogen. Phys Med Biol (1992) 0.78
Cadmium in Shipham. Lancet (1979) 0.78
Design of a phantom equivalent to measure bone-fluorine in a human's hand via delayed neutron activation analysis. Physiol Meas (2013) 0.78
Effect of sample preparation techniques on the concentrations and distributions of elements in biological tissues using µSRXRF: a comparative study. Physiol Meas (2015) 0.77
In vivo neutron activation analysis of organ cadmium burdens. Referent levels in liver and kidney and the impact of smoking. Biol Trace Elem Res (1991) 0.77
Study of the relationships between bone lead levels and its variation with time and the cumulative blood lead index, in a repeated bone lead survey. J Environ Monit (2000) 0.77
Development and calibration of an in vivo bone lead measurement system, and its application to an industrially exposed population. Basic Life Sci (1993) 0.77
Serum (plasma) lead, blood lead, and bone lead. Am J Ind Med (1997) 0.77
A transportable system for the measurement of liver cadmium in vivo. Phys Med Biol (1979) 0.77
Quantification of manganese in human hand bones: a feasibility study. Phys Med Biol (2008) 0.77
Calculation of radiation-induced DNA damage from photons and tritium beta-particles. Part I: Model formulation and basic results. Radiat Environ Biophys (2001) 0.77
Whole body cellular and collagen nitrogen in healthy and wasted man. Clin Sci (Lond) (1984) 0.76
Factors affecting ultraviolet-A photon emission from β-irradiated human keratinocyte cells. Phys Med Biol (2015) 0.76
Measurements of fluorine in contemporary urban Canadians: a comparison of the levels found in human bone using in vivo and ex vivo neutron activation analysis. Physiol Meas (2015) 0.76
The feasibility of measuring manganese concentrations in human liver using neutron activation analysis. Neurotoxicology (1999) 0.76
Monte Carlo simulation of trabecular bone remodelling and absorbed dose coefficients for tritium and 14C. Radiat Prot Dosimetry (2007) 0.76
Application of spectral decomposition analysis to in vivo quantification of aluminum by neutron activation analysis. Appl Radiat Isot (2004) 0.75
Birmingham Medical Research Expeditionary Society 1977 Expedition: effect of a Himalayan trek on whole body composition, nitrogen and potassium. Postgrad Med J (1979) 0.75
The use of multiple parameters to characterize cadmium-induced renal dysfunction resulting from occupational exposure. Environ Res (1994) 0.75
Improvements to the in vivo measurement of cadmium in the kidney by neutron activation analysis. Appl Radiat Isot (1998) 0.75
Feasibility studies in the in vivo measurement of iron in synovial membrane. Basic Life Sci (1990) 0.75
On the in vivo measurement of mercury using neutron capture and x-ray fluorescence. Int J Appl Radiat Isot (1982) 0.75